Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, marketing and advertising agencies.Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.…
Healthcare Leaders Turn Months-Long Analyses Into Minutes With AI-Powered Growth Intelligence Platform
Definitive Healthcare (NASDAQ: DH) is listed on Nasdaq, where its shares trade in USD. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 678 employees.
The shares were at 1.200 USD on 20 November 2026, down 59.0% over 52 weeks. Its 52-week range is 0.6103 USD to 3.000 USD: the price is 60.0% below the high and 96.6% above the low.
Its market capitalisation is 128.60M USD.
Definitive Healthcare reports return on equity of -49.4%, an operating margin of -9.2% and revenue down 9.0% year over year.
It holds more cash than debt, a net cash position of 26.13M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 4 analysts cover the stock, with an average rating of Hold; their mean price target of 1.625 USD is 35.4% above the current price. The next earnings report is expected on 25 February 2027.